#200 COVID-19 with Paul Sax MD - Transmission, quarantine, PPE, diagnosis and management

Practical tips and discussion of what we do and don’t know about COVID-19 transmission, testing, NSAIDs, ACE inhibitors, quarantine, treatment, personal protective equipment (PPE) and more with Paul Sax MD, @paulsaxMD (Brigham and Women’s Hospital/Harvard Medical School). This episode is sure to go viral! Show Notes | Spotify | Swag! | Top Picks | Mailing List | [email protected] Written and Produced by: Sarah Phoebe Roberts MPH; Chris Chiu MD; Beth Garbitelli; Hannah Abrams; Rahul Ganatra MD, MPH; Matthew Watto MD, FACP Cover Art and Infographic by: Beth Garbitelli Hosts: Rahul Ganatra MD, MPH; Matthew Watto MD, FACP; Paul Williams MD, FACP Editor: Matthew Watto MD (written materials); Clair Morgan of nodderly.com Guest: Paul Sax MD Sponsor: CayugaTime Stamps 00:00 Intro 04:12 SARS-CoV-2/COVID-19 vs. SARS, MERS, and influenza 07:00 Rahul highlights areas of caution interpreting COVID cases studies 12:35 Sponsor 13:20 Case of cold symptoms; Wearing masks in public; Advice on self quarantine with mild symptoms 18:05 Patient with mild symptoms and COVID exposure; Duration of quarantine and PCR positivity 21:15 Who merits testing for COVID-19 23:19 Case of confirmed COVID with mild symptoms; Instructions to patient and family about quarantine 25:50 COVID-19 testing characteristics (sensitivity, false negatives); Does co-infection occur?; Advice on when to send patient to a hospital 30:10 ACEIs, ARBs, NSAIDS; Is reinfection possible? 32:20 Pharmacotherapy: Hydroxychloroquine, Remdesivir, Tocilizumab; Definition of the “high risk” patient; COVID-19 vaccine 36:50 Case of healthcare worker (HCW) with COVID exposure; How long can COVID live on surfaces? 40:20 Do exposed HCWs without symptoms require quarantine? 41:30 Personal Protective equipment (PPE) 45:00 COVID-19 in pregnancy 47:30 COVID-19 and vulnerable patient populations (patients who are immigrants, homeless, incarcerated, etc.) 50:45 Where should you get your COVID-19 information? 52:30 Closing remarks and outro